Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Tirzepatide for Sale > tirzepatide 40mg 99% purity white raw powder 1
tirzepatide 40mg 99% purity white raw powder 1 buy - large image1
tirzepatide 40mg 99% purity white raw powder 1 buy - image1
tirzepatide 40mg 99% purity white raw powder 1 buy - image2
tirzepatide 40mg 99% purity white raw powder 1 buy - image3
tirzepatide 40mg 99% purity white raw powder 1 buy - image4
tirzepatide 40mg 99% purity white raw powder 1 buy - image5
tirzepatide 40mg 99% purity white raw powder 1 buy - image6

tirzepatide 40mg 99% purity white raw powder 1

2081 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

40mg/Vial

Price valid (until):

2026-10-03

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  





    Tirzepatide 40mg Peptide Research Compound Lyophilized Powder Material

    Product Overview

    Tirzepatide 40mg Peptide Research Compound is a synthetic peptide research material supplied in a lyophilized powder format. This product is designed for laboratory research applications in peptide science, biochemical analysis, molecular studies, and related scientific fields.

    Tirzepatide is a synthetic peptide compound also known as LY3298176. The compound is identified by CAS No. 2023788-19-2, with molecular formula C225H348N48O68 and molecular weight approximately 4813.45 g/mol.

    The product is supplied in a standardized 30mg vial specification, providing researchers with a convenient format for laboratory evaluation, analytical testing, and research material management. The product is presented as a white to off-white lyophilized powder suitable for research use. 

    This product is supplied strictly as a research material and is intended for laboratory research applications only.


    Product Information

    Product Name:
    Tirzepatide 40mg Peptide Research Compound Lyophilized Powder Material

    Product Category:
    Synthetic Peptide Research Compound

    Specification:
    40mg/vial

    Appearance:
    White to off-white lyophilized powder 

    Physical Form:
    Freeze-dried powder

    CAS Number:
    2023788-19-2 

    Molecular Formula:
    C225H348N48O68 

    Molecular Weight:
    Approximately 4813.45 g/mol

    Research Classification:
    Research Use Only (RUO)


    Chemical Information

    Compound Name: Tirzepatide

    Alternative Name: LY3298176 

    CAS No.: 2023788-19-2 

    Chemical Type: Synthetic peptide compound

    Formula: C225H348N48O68 

    Tirzepatide is a complex peptide molecule produced through controlled synthesis processes. Due to its peptide characteristics, proper storage, handling, and laboratory management procedures are recommended to maintain product quality.


    Product Characteristics

    Synthetic Peptide Research Material

    Tirzepatide 40mg is supplied as a synthetic peptide compound designed for scientific research applications.

    Main product characteristics:

    • Synthetic peptide structure
    • Standardized 30mg specification
    • Lyophilized powder format
    • Professional vial packaging
    • Laboratory research application

    Lyophilized Powder Format

    The product is provided in freeze-dried powder form, which is commonly used for peptide research materials.

    Advantages of lyophilized format include:

    • Convenient storage management
    • Reduced moisture exposure
    • Easy transportation
    • Compatibility with laboratory workflows

    The product appearance is typically white to off-white powder. 


    Standardized 40mg Packaging

    The 40mg vial specification provides researchers with a practical quantity for laboratory planning and material management.

    Packaging advantages:

    • Clear product identification
    • Convenient storage
    • Easy batch management
    • Suitable for research inventory control

    Technical Specifications

    Item Specification
    Product Name Tirzepatide 30mg Peptide Research Compound
    Product Type Synthetic Peptide Material
    CAS No. 2023788-19-2
    Specification 40mg/vial
    Appearance White to off-white powder
    Form Lyophilized powder
    Molecular Formula C225H348N48O68
    Molecular Weight Approx. 4813.45 g/mol
    Grade Research Grade
    Application Laboratory Research

    Research Applications

    Peptide Chemistry Research

    Tirzepatide 40mg may be used as a reference compound in peptide-related studies.

    Potential research activities include:

    • Peptide characterization
    • Structural evaluation
    • Analytical method development
    • Molecular research

    Biochemical Analysis

    The product may support laboratory studies involving peptide analysis and compound evaluation.

    Possible applications include:

    • Identity testing
    • Purity analysis
    • Analytical comparison
    • Research methodology development

    Molecular Research

    Tirzepatide research material may be evaluated in scientific studies involving:

    • Peptide molecular characteristics
    • Compound analysis
    • Laboratory reference studies
    • Research model development

    Analytical Research

    Common analytical methods used for peptide research materials include:

    • High Performance Liquid Chromatography (HPLC)
    • Mass Spectrometry (MS)
    • Molecular characterization analysis

    Quality documentation for Tirzepatide research materials may include analytical information such as appearance, purity testing, molecular identification, and batch verification. 


    Manufacturing Information

    Tirzepatide 40mg is produced through controlled peptide synthesis and purification procedures.

    The manufacturing process focuses on:

    • Raw material evaluation
    • Controlled synthesis conditions
    • Purification process management
    • Product identification
    • Quality verification

    Manufacturing controls help maintain product consistency and support scientific research requirements.


    Quality Control

    Quality Management

    Quality control procedures are implemented to verify product characteristics and batch consistency.

    Quality evaluation may include:

    • Appearance inspection
    • Identity confirmation
    • Purity analysis
    • Batch documentation review
    • Analytical testing

    Analytical Testing

    HPLC Analysis

    High Performance Liquid Chromatography may be used for peptide purity evaluation and analytical characterization.

    Mass Spectrometry

    Mass spectrometry may be used for molecular weight confirmation and compound identification.

    Physical Inspection

    Physical examination may evaluate:

    • Powder appearance
    • Packaging condition
    • Product labeling

    Packaging Details

    Standard Package

    Product: Tirzepatide 40mg

    Package Type: Sealed laboratory vial

    Product Form: Lyophilized powder

    Net Content: 40mg per vial

    The packaging system is designed to support product protection, identification, and laboratory material management.


    Storage Recommendations

    Recommended storage practices:

    • Keep vial sealed before use
    • Store in a controlled laboratory environment
    • Protect from moisture
    • Avoid unnecessary temperature fluctuations
    • Follow laboratory storage procedures

    Proper storage conditions help maintain product quality and support reliable research applications.


    Handling Information

    Tirzepatide 40mg should be handled by qualified laboratory personnel.

    Recommended practices:

    • Follow laboratory safety procedures
    • Use suitable laboratory equipment
    • Maintain clean working conditions
    • Keep accurate material records
    • Follow institutional requirements

    Product Advantages

    Professional Research Specification

    The standardized 40mg vial format provides researchers with a convenient quantity for laboratory planning.

    High-Quality Peptide Format

    The lyophilized powder form supports convenient storage and handling.

    Clear Product Identification

    Detailed product information and batch records support laboratory management.

    Research Compatibility

    The product is suitable for peptide analysis, biochemical studies, and molecular research activities.


    Product Keywords

    Tirzepatide 40mg

    Tirzepatide Peptide

    LY3298176

    Synthetic Peptide Compound

    Research Grade Peptide

    Lyophilized Powder Material

    Peptide Research Reagent

    Laboratory Research Compound

    Biochemical Research Material

    Molecular Research Compound


    Frequently Asked Questions (FAQ)

    What is Tirzepatide 30mg?

    Tirzepatide 40mg is a synthetic peptide research compound supplied in lyophilized powder form for laboratory research applications.

    What is the CAS number?

    The CAS number of Tirzepatide is 2023788-19-2.

    What is the specification?

    The standard specification is 40mg per vial.

    What is the product appearance?

    The product is supplied as white to off-white lyophilized powder. 

    What are the main applications?

    The product is used as a research material for peptide analysis, biochemical studies, molecular research, and laboratory evaluation.

    Is this product for human use?

    No. This product is supplied as a research material and is intended for laboratory research applications only.


    Echemi Short Product Description

    Tirzepatide 40mg Peptide Research Compound is a synthetic peptide material supplied as white to off-white lyophilized powder. With a standardized 30mg/vial specification, this research compound is suitable for peptide analysis, biochemical research, molecular studies, and laboratory evaluation. Supplied as a Research Use Only material.


    Echemi Product Highlights

    • Synthetic peptide research compound
    • CAS No. 2023788-19-2
    • 40mg/vial standardized specification
    • White to off-white lyophilized powder
    • Professional laboratory packaging
    • Suitable for peptide and biochemical research
    Items Specifications
    Product Name tirzepatide
    Grade Research Grade
    Package 40mg/Vial
    Appearance White Lyophilized Powder
    Model tirzepatide 40mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference

    Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Characteristics
    Appearance:

    White to off-white

    Research
    Class:

    Dual agonist — GIPR, GLP-1R

    Status:

    FDA-approved (Mounjaro / Zepbound)

    Mechanism:

    Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.

    EC50 (Human GLP1R):

    0.934 nM

    EC50 (Human GIPR):

    0.0224 nM

    Source:

    Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI

    FDA:

    Mounjaro, Zepbound (approved 2022-05-13)

    References
    ChEMBL:

    CHEMBL4297839

    DrugBank:

    DB15171

    KEGG DRUG:

    D11360

    PubChem:

    PubChem

    Disclaimer:

    Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    2081 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Hongkong, China

    2023788-19-2

    1 KG Aug 13, 2026
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    United Kingdom

    tirzepatide

    10 MG Oct 21, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.